The drugmaker’s U.S. plans comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% year ...
GSK is investing up to $800 million to double the size and capacity of its production site in Marietta, Pennsylvania, the company said Thursday. Through the addition of two new facilities ...
A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. The UK ...
BUCKSCO.Today on MSN7d
A Planned GSK Expansion Pushes Company Beyond Montgomery CountyGlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment ...
GSK (GSK) plc announced what it calls its ... manufacturing capabilities to the company’s site in Marietta, Pennsylvania, along with over 200 new jobs, the company stated.
GlobalData on MSN17d
GSK pumps up to $800m for US manufacturing site upgradeA new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley ...
MARIETTA, Pa. (WHTM) — A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster County manufacturing facility. During a press ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback